There is much evidence that neutrophil gelatinase-associated lipocalin (NGAL) is an AKI-specific biomarker that can be measured in plasma and urine [22,23], but also is expressed in nephrons during damage development [24]. This evidence concerns the gene LCN2 and acute kidney injury.